Says passed some “amazing milestones” in Q4. Says closed more than 400 deals over $1M in Q4. Remains “deeply committed” to profitable growth. Says Data Cloud and Agentforce have the potential to be multi-billion product lines. Says customers seeing “great success” with Agentforce. Says currently has 3,000 Agentforce customers. Says Pfizer (PFE) to use Salesforce (CRM) Life Sciences Cloud. Says has a lot more “groundbreaking innovation” coming. Comments taken from Q4 earnings conference call.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRM:
- CRM Earnings: Salesforce Stock Sinks on Mixed Financial Results
- Salesforce reports Q4 adjusted EPS $2.78, consensus $2.61
- Salesforce sees FY26 revenue $40.5B-$40.9B, consensus $41.36B
- Salesforce sees Q1 adjusted EPS $2.53-$2.55, consensus $2.62
- Salesforce sees FY26 adjusted EPS $11.09-$11.17, consensus $11.21